ARCS Weekly News Wrap – Week Ending 25 October 2025

This week’s episode covers a powerhouse mix of policy shifts, scientific breakthroughs, and leadership changes shaping Australia’s life sciences landscape.

Join Tim Boyle, CEO of ARCS Australia, as he unpacks:

• Pharma: Landmark PBS listings, proactive pharmacovigilance, and new rare disease breakthroughs

• Medtech: HTA review tensions, hospital funding reform, and insights from the MTAA Conference

• Biotech & Investment: A wave of clinical trials, capital raises, and global research collaborations

• People Movement: Leadership transitions at Gilead, Moderna, and Omico that will influence the sector’s next chapter

• Partner with ARCS: How collaboration continues to drive innovation and workforce capability across the life sciences ecosystem

It’s a fast-paced, insightful wrap of the week’s most important developments — helping you stay informed, connected, and ahead of the curve.

🎥 Watch the full episode now and don’t miss your chance to be part of the only professional network that connects every corner of the Australian life sciences sector.

👉 Join ARCS today: www.arcs.com.au/join

#ARCSWeeklyWrap #LifeSciences #Pharma #Medtech #Biotech #ARCSAustralia #ARCS2025Leaders